journal article·2023-01Open access

Intercalation of atorvastatin and valsartan into Mg Al layered double hydroxide host using a restacking procedure

Szabolcs Muráth, Natálie Dvorníková, Daniel Moreno-Rodríguez, Radek Novotný, Miroslav Pospíšil, Martina Urbanová, Jiří Brus, František Kovanda

Abstract

Anionic drugs very poorly soluble in water, namely antidyslipidemic atorvastatin and antihypertensive valsartan were intercalated into MgAl LDH host using a restacking procedure, when the drugs, dissolved in ethanol, were added to aqueous dispersion of LDH nanosheets, prepared by direct coprecipitation of Mg and Al nitrates in excess of aqueous ammonia solution under nitrogen. Despite the large size of intercalated molecules, the products with high drug loading were obtained; the content 75.8 wt% of atorvastatin and 43.7 wt% of valsartan corresponded to 100 and 60% of the LDH anion exchange capacity, respectively. A marked increase in d003 basal spacing from 0.876 to 3.808 and 2.068 nm observed in powder XRD patterns of the LDH intercalated with atorvastatin and valsartan, respectively, confirmed the intercalation of both drugs into the LDH interlayer. The computational modeling applying the force field methods was used to calculate the most probable arrangement of the interlayer components at the atomic scale through energy minimization. The final models showed good agreement between the calculated and experimentally determined d003 basal spacing values. Results of the molecular modeling confirmed weak electrostatic interactions between LDH layers and terminal carboxyl groups in the drug molecules, together with bonding between the valsartan tetrazole rings and the LDH layers. Such interactions accompanied by deprotonation of carboxyl groups and tetrazole rings in the intercalated products were indicated by the FTIR and NMR measurements. The intercalation of drugs into LDH host slightly affected their back-release in aqueous media. In the phosphate buffer, slower atorvastatin release from the intercalated product compared to the sample containing atorvastatin calcium salt was observed, whereas enhanced valsartan release from the intercalated sample was found in the diluted HCl. The measured release profiles corresponded to the pseudo-second-order kinetics, indicating an intraparticle diffusion as the rate-limiting step.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Inorganic Chemistry and Materials · Magnesium Oxide Properties and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Materials Studio modelling environment
2. Delamination of layered double hydroxides by use of surfactants10.1039/a908251d ↗
3. Die Struktur des Hydrotalkits
4. Hybrid compounds for improving drugs solubility: Synthesis, physico-chemical and pharmaceutical characterization of Nimesulide-LDH10.1016/j.jssc.2019.02.001 ↗
5. Heating of samples induced by fast magic-angle spinning10.1016/S0926-2040(00)00061-8 ↗
6. Anticancer drug encapsulated in inorganic lattice can overcome drug resistance10.1039/b925831k ↗
7. NMR crystallography of the polymorphs of metergoline10.3390/cryst8100378 ↗
8. Layered double hydroxides10.1016/S1572-4352(05)01039-1 ↗
9. Direct synthesis of alkoxide-intercalated derivatives of hydrocalcite-like layered double hydroxides: Precursors for the formation of colloidal layered double hydroxide suspensions and transparent thin films10.1002/1521-4095(200108)13:16<1263::AID-ADMA1263>3.0.CO;2-R ↗
10. Enhanced effects of low molecular weight heparin intercalated with layered double hydroxide nanoparticles on rat vascular smooth muscle cells10.1016/j.biomaterials.2010.03.050 ↗
11. Layered double hydroxide nanoparticles: Impact on vascular cells, blood cells and the complement system10.1016/j.jcis.2017.10.069 ↗
12. Thermodynamically consistent force fields for the assembly of inorganic, organic, and biological nanostructures: the INTERFACE force field10.1021/la3038846 ↗
13. Canonical dynamics: Equilibrium phase-space distributions10.1103/PhysRevA.31.1695 ↗
14. Computational study and spectroscopic investigations of antihypertensive drugs10.1016/j.vibspec.2012.04.009 ↗
15. Preparation of 5-fluorouracil/β-cyclodextrin complex intercalated in layered double hydroxide and the controlled drug release properties10.1021/ie100990z ↗
16. Boosting the anticancer activity of doxorubicin with a layered double hydroxide nanocarrier10.1016/j.clay.2021.106000 ↗
17. Synthetic hydroltalcite-like compounds
18. Intercalation of paracetamol into the hydrotalcite-like host10.1016/j.jssc.2011.10.029 ↗
19. Temperature calibration under ultrafast MAS conditions10.1006/jmre.1999.1717 ↗
20. One-pot-synthesis of the organomodified layered double hydroxides - glibenclamide biocompatible nanoparticles10.1016/j.colsurfb.2020.111055 ↗
21. Amorphization of atorvastatin calcium by mechanical process: characterization and stabilization within polymeric matrix10.1007/s12247-017-9282-0 ↗
22. Synthesis and controlled release properties of prednisone intercalated Mg-Al layered double hydroxide composite10.1021/ie900043r ↗
23. Positively charged nanosheets derived via total delamination of layered double hydroxides10.1021/cm0510460 ↗
24. Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles10.1016/j.biomaterials.2013.12.095 ↗
25. High and long-term antibacterial activity against Escherichia coli via synergy between the antibiotic penicillin G and its carrier ZnAl layered double hydroxide10.1016/j.colsurfb.2018.11.035 ↗
26. Intercalation of norfloxacin into layered double hydroxides by delamination/restacking process and its controlled-release property10.1080/01932691.2015.1025906 ↗
27. Synthesis and characterization of camptothecin-rhamnolipid-layered double hydroxide nanohybrid and its controlled release property10.1080/01932691.2019.1627880 ↗
28. Intercalation of methotrexatum into layered double hydroxides via exfoliation-reassembly process10.1016/j.apsusc.2015.01.047 ↗
29. Facile fabrication of ibuprofen–LDH nanohybrids via a delamination/reassembling process10.1016/j.materresbull.2012.12.057 ↗
30. Method of UV-metric and pH-metric determination of dissociation constants of ionizable drugs: valsartan10.1007/s10953-019-00913-y ↗
31. Meloxicam-LDH hybrid compound: a successful strategy to improve solubility10.1007/s10904-019-01230-z ↗
32. Molecular modeling of hydrotalcite structure intercalated with transition metal oxide anions: CrO42− and VO43−10.1021/jp2079499 ↗
33. Neutral nanosheets that gel: Exfoliated layered double hydroxides in toluene10.1021/jz2004655 ↗
34. Controlled release of drug from cyclodextrin-intercalated layered double hydroxide10.1016/j.jpcs.2007.10.027 ↗
35. Degradation kinetics of atorvastatin under stress conditions and chemical analysis by HPLC10.3390/molecules18021447 ↗
36. Spectroscopic studies on photodegradation of atorvastatin calcium10.1038/s41598-021-94693-5 ↗
37. In-vitro release kinetics and stability of anticardiovascular drugs-intercalated layered double hydroxide nanohybrids10.1021/jp905440e ↗
38. A molecular dynamics framework to explore the structure and dynamics of layered double hydroxides10.1016/j.clay.2018.06.037 ↗
39. Structural arrangement and properties of layered double hydroxide drug nanocarrier intercalated by sulindac and mefenamic acid solved by molecular simulation methods10.1016/j.clay.2020.105560 ↗
40. Charge equilibration for molecular dynamics simulations10.1021/j100161a070 ↗
41. Layered double hydroxides as drug carriers and for controlled release of non-steroidal antiinflammatory drugs (NSAIDs): a review10.1016/j.jconrel.2013.03.034 ↗
42. Intercalation of drugs in layered double hydroxides and their controlled release: a review10.1016/j.clay.2013.12.002 ↗
43. High-field and high-speed CP-MAS13C NMR heteronuclear dipolar-correlation spectroscopy of solids with frequency-switched Lee–Goldburg homonuclear decoupling10.1006/jmre.1996.1089 ↗
44. Advanced drug delivery applications of layered double hydroxide10.1016/j.jconrel.2020.12.041 ↗
45. Mg/Al ordering in layered double hydroxides revealed by multinuclear NMR spectroscopy10.1126/science.1157581 ↗
46. Layered double hydroxides as promising excipients for drug delivery purposes10.1016/j.ejps.2021.105922 ↗
47. COMPASS: an ab initio force-field optimized for condensed-phase applications. Overview with details on alkane and benzene compounds10.1021/jp980939v ↗
48. Self-assembly of delaminated layered double hydroxide nanosheets for the recovery of lamellar structure10.1016/j.colcom.2021.100564 ↗
49. Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides10.1016/j.ijpharm.2006.09.031 ↗
50. Interaction pathways and structure-chemical transformations of alginate gels in physiological environments10.1021/acs.biomac.9b01052 ↗
51. Effect of various factors influencing the delamination behavior of surfactant intercalated layered double hydroxides10.1016/j.jcis.2005.06.086 ↗
52. Molekulární simulace ve strukturní analýze interkalátů. Diploma thesis
53. Highly crystalline forms of valsartan with superior physicochemical stability10.1021/cg400762w ↗
54. Acetate-intercalated Ni-In layered double hydroxides with low infrared emissivity: Synthesis, delamination and restacked to form the multilayer films10.1016/j.apsusc.2013.10.109 ↗
55. Synthesis and properties of Mg2Al layered double hydroxides containing 5-fuorouracil10.1016/j.jssc.2004.11.005 ↗
56. Layered double hydroxide nanostructures and nanocomposites for biomedical applications10.1039/C9TB01312A ↗
57. Large-scale aqueous synthesis of layered double hydroxide single-layer nanosheets10.1016/j.colsurfa.2016.04.046 ↗